Accentia Biopharmaceuticals Inc. (ABPI) Subsidiary Releases Positive Results for Clinical Trial of Non-Hodgkin’s Lymphoma Treatment
Biovest International Inc. (OTCBB: BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals Inc. (NASDAQ:ABPI), today announced “highly encouraging” results for its…